Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan
scientific article published on 28 May 2022
Author/s
author: Francisca Guijarro, Alex Bataller, Christelle Ferrà, Olga Salamero, Mar Tormo, Antonia Sampol, Carmen Martínez, Juan Carlos Hernandez-Boluda, Sierra Jorge, Jordi Esteve, David Valcarcel
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.